Skip to main content
. Author manuscript; available in PMC: 2012 Mar 15.
Published in final edited form as: J Biomech. 2011 Jan 20;44(5):848–855. doi: 10.1016/j.jbiomech.2010.12.007

Figure 5.

Figure 5

a: Western blotting for ERK activation of nHDF in constructs formed and stretched on FlexCell membranes. Treatment conditions were with and without TGF-β1 and p38 inhibitor SB203580, with and without cyclic stretching at 10% strain amplitude and 0.5 Hz. b: Ratio of pERK/tERK under cyclic stretching at 1 hour normalized to the same treatment with static incubation. c: Ratio of pERK/tERK under cyclic stretching at 1 week normalized to the same treatment with static incubation. d: Ratio of Collagen/Cell concentrations after 1 week.